SCHEMBL22245019

SCHEMBL22245019

COc1c(C(=O)O)ccc(Br)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.56
MAPT P10636 1/20 0.56
HSD17B10 Q99714 2/20 0.51
TPMT P51580 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
AKR1C3 P42330 3/20 0.40
AKR1C2 P52895 3/20 0.40
AKR1C4 P17516 2/20 0.40
AKR1C1 Q04828 2/20 0.40
GPR35 Q9HC97 1/20 0.40
PTPN2 P17706 2/20 0.40
PTPN1 P18031 2/20 0.40
PTPN6 P29350 2/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
SELL P14151 1/20 0.39
SELP P16109 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6215179 0.85 HSD17B10 (0.55) TDP1MAPTHSD17B10TPMTLCK
SCHEMBL6930173 0.81 HSD17B10 (0.51) TDP1MAPTHSD17B10TPMTLCK
SCHEMBL1987207 0.81 HSD17B10 (0.51) TDP1MAPTHSD17B10TPMTLCK
SCHEMBL1438720 0.81 TDP1 (0.59) TDP1MAPTHSD17B10TPMTALDH1A1
SCHEMBL30316357 0.80 HSD17B10 (0.50) TDP1MAPTHSD17B10TPMTLCK
SCHEMBL1505827 0.80 TDP1 (0.61) TDP1MAPTHSD17B10LCKFYN
SCHEMBL28841565 0.79 TDP1 (0.58) TDP1MAPTHSD17B10ALDH1A1KDM4E
SCHEMBL7127616 0.79 HSD17B10 (0.53) TDP1MAPTHSD17B10TPMTLCK
SCHEMBL11026756 0.79 MAPT (0.73) TDP1MAPTHSD17B10TPMTLCK
SCHEMBL24165077 0.78 HSD17B10 (0.51) TDP1MAPTHSD17B10TPMTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020148354-A1 SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2020-07-23 WO disclosed